Publications by authors named "Alan Solomon"

Claim this Profile
M
Management of AL amyloidosis in 2021.
Alan Solomon

Amyloid· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.
Camille Vanessa Edwards, Nisha Rao, Divaya Bhutani, Markus Mapara, Jai Radhakrishnan, Alan Solomon

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.
Alan Solomon

N Engl J Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.
Camille V Edwards, Divaya Bhutani, Markus Mapara, Jai Radhakrishnan, Sofia Shames, Alan Solomon

Amyloid· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.
Camille V Edwards, Julia Gould, Arielle L Langer, Markus Mapara, Jai Radhakrishnan, Alan Solomon

Amyloid· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG Conformer's Binding to Amyloidogenic Aggregates.
Monichan Phay, Alfred T Welzel, Angela D Williams, Helen P McWilliams-Koeppen, Veronika Blinder, Alan Solomon

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.
Yona Levites, Brian O'Nuallain, Rama Devudu Puligedda, Tomas Ondrejcak, Sharad P Adekar, Alan Solomon

J Neurosci· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis.
Christopher P Larsen, Robert J Kossmann, Marjorie L Beggs, Alan Solomon, Patrick D Walker

Kidney Int· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human anti-Aβ IgGs target conformational epitopes on synthetic dimer assemblies and the AD brain-derived peptide.
Alfred T Welzel, Angela D Williams, Helen P McWilliams-Koeppen, Luis Acero, Alfred Weber, Alan Solomon

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.
James S Foster, Lindsay M Fish, Jonathan E Phipps, Charles T Bruker, James M Lewis, Alan Solomon

BMC Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of anti-AA amyloid-specific monoclonal antibodies.
Jonathan S Wall, Stephen J Kennel, Tina Richey, Amy Allen, Alan Stuckey, Alan Solomon

Front Immunol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and evaluation of agents for targeting visceral amyloid.
Jonathan S Wall, Alan Solomon, Stephen J Kennel

Tijdschr Nucl Geneeskd· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
ODAM Expression Inhibits Human Breast Cancer Tumorigenesis.
Daniel P Kestler, James S Foster, Charles T Bruker, John W Prenshaw, Stephen J Kennel, Alan Solomon

Breast Cancer (Auckl)· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series.
Charles L Murphy, Shuching Wang, Daniel Kestler, Christopher Larsen, Don Benson, Alan Solomon

Am J Kidney Dis· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of pathologic immunoglobulin-free light chain production by small interfering RNA molecules.
Jonathan E Phipps, Daniel P Kestler, James S Foster, Stephen J Kennel, Robert Donnell, Alan Solomon

Exp Hematol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AA amyloidosis associated with a mutated serum amyloid A4 protein.
Charles L Murphy, Shuching Wang, Daniel P Kestler, Fred A Stevens, Deborah T Weiss, Alan Solomon

Amyloid· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.
Jonathan S Wall, Stephen J Kennel, Alan C Stuckey, Misty J Long, David W Townsend, Alan Solomon

Blood· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies.
Christopher P Larsen, Patrick D Walker, Deborah T Weiss, Alan Solomon

Kidney Int· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-amyloidogenic activity of IgGs contained in normal plasma.
Brian O'Nuallain, Angela D Williams, Helen P McWilliams-Koeppen, Luis Acero, Alfred Weber, Alan Solomon

J Clin Immunol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherent anti-amyloidogenic activity of human immunoglobulin gamma heavy chains.
Sharad P Adekar, Igor Klyubin, Sally Macy, Michael J Rowan, Alan Solomon

J Biol Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odontogenic ameloblast associated protein as a novel biomarker for human breast cancer.
Sabina Siddiqui, C Todd Bruker, Daniel P Kestler, James S Foster, Keith D Gray, Alan Solomon

Am Surg· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A father and his son with systemic AL amyloidosis.
Stina Enqvist, Ulf-Henrik Mellqvist, Johan Mölne, Knut Sletten, Charles Murphy, Alan Solomon

Haematologica· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenic plasma cells can serve as a source of amyloidogenic light chains.
Alan Solomon, Sallie D Macy, Craig Wooliver, Deborah T Weiss, Per Westermark

Blood· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative tomography of early-onset spontaneous AA amyloidosis in interleukin 6 transgenic mice.
Jonathan S Wall, Tina Richey, Amy Allen, Robert Donnell, Steve J Kennel, Alan Solomon

Comp Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies.
Brian O'Nuallain, Luis Acero, Angela D Williams, Helen P McWilliams Koeppen, Alfred Weber, Alan Solomon

Biochemistry· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis